248 Results
Symptom Management
Symptom Management
Symptom Management
Guidelines and Advice
Status: Current
ID: GL 1-22-A
Version: 2
ID: GL 1-22-A
Version: 2
Jul 2022
Guidelines and Advice
Status: In-Review
ID: GL-3-A-2016-1
ID: GL-3-A-2016-1
Mar 2017
Document
Dec 1969
Document
Dec 1969
Document
Dec 1969
Guidelines and Advice
Status: Current
ID: GL-C50-25
ID: GL-C50-25
Dec 1969
Drug
Other Name(s): Suprefact®
, Suprefact Depot®
, Suprefact Nasal Spray®
Nov 2024